The increasing use of G-protein - coupled receptors is expected to boost demand for G protein-coupled receptors in drug disclosure and advancement ways. In the global market for G-protein coupled receptors, there is an increase in government funding for R&D activities. A growing number of receptor-targeted allosteric modulators, biological drugs, and biassed agonists are escalating the need for assays in the market for G-protein - coupled receptors. This, in essence, has resulted in the successful detection of drug candidates that are pharmaceutically important, driving the adoption of these receptors in the process of drug development. In clinical and preclinical trials, the presence of large numbers of licenced medicines and drugs targeting these receptors raises the need for GPCR screening assays in drug production.
The global G-Protein Coupled Receptors Market 2020 is poised to cross USD 4.2 billion by 2025 at a CAGR of 7.1% over the review period.
The high costs involved in sustaining GPCR cell lines are, however, likely to curb the development of the global demand for G protein coupled receptors. The global G protein-coupled receptors market is currently dominated by many market players. To strengthen their market positions, key players are involved in product launches and strategic collaborations.
Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/8356
Competitive Dashboard
Some of the eminent players in the global G protein-coupled receptor market are Thermo Fisher Scientific, Inc., Abcam PLC, PerkinElmer Inc., Promega Corporation, Merck Group, HD Biosciences Co., Ltd, QIAGEN, Cisbio, Enzo Life Sciences, and Inc.BD.
Segmentation
The global market for G-protein coupled receptors has been segmented based on the Product, Assay Type, and Application.
- Based on the Product, the market has been divided into cell lines, detection kits, cell culture reagents, ligands, and others. The segment for detection kits are plausible to be the fastest during the evaluation period as they are ready to use kits that include all cells and reagents to conduct functional GPCR assay in live cells, thereby pushing the growth of the global G protein coupled receptor market.
- Based on Assay Type, the global G-protein coupled receptor market has been segmented into functional calcium assays, cGMP assays, internalization assays, GTP gamma S binding assays, cAMP functional assays, ß-Arrestin Functional Assays, and others. Calcium functional assays are the strongest segment, with numerous advantages, such as user configurability and ease in estimating calcium flux, thereby driving this segment's growth in the GPCR market.
- Based on the Application, the global G protein coupled receptors market has been segmented into the cardiovascular system, oncology, respiratory system, immunology, central nervous system, and others. The cardiovascular system is a significant segment of angiotensin II, and β-adrenergic receptors provide treatment for a wide variety of cardiovascular disorders, such as heart failure. Nearly 17.9 million people die every year from cardiovascular disease, therefore increasing the G-protein coupled receptor market.
Regional Analysis
Regionally, the market for G-protein coupled receptors has been divided into the Americas, Europe, the Asia Pacific, and the Middle East & Africa.
The Americas is estimated to be the leading market due to the presence of a large number of approved drugs targeting G-protein coupled receptors. The market for G-protein coupled receptors in the Americas was further divided into North America and Latin America, with the North American market divided into the United States and Canada.
Get Access Full Report @ https://www.marketresearchfuture.com/reports/g-protein-coupled-receptors-market-8356
The European G-protein coupled receptor market has been classified as Western Europe and Eastern Europe. The Western European market has also been classified as Germany, France, the United Kingdom, Italy, Spain, and the rest of Western Europe.
The market for G-protein coupled receptors in the Asia Pacific has been segmented into China, Japan, South Korea, India, Australia, and the rest of the Asia Pacific. The number of approved drugs targeting GPCRs has propelled the growth of the G-protein coupled receptor market and is projected to be the fastest-growing market in the Asia Pacific. The market for G-protein coupled receptors in the Middle East and Africa has been divided into the Middle East and Africa.
